Aberrant Expression of Regulatory Cytokine IL-35 and Pattern Recognition Receptor NOD2 in Patients with Allergic Asthma

Inflammation

Volumn 38, Issue 1, 2015, Pages 348-360

  Wong, Chun Kwok ^a,b   Leung, Ting Fan ^a   Chu, Ida Miu Ting ^a   Dong, Jie ^a,b   Lam, Yvonne Yi On ^a   Lam, Christopher Wai Kei ^a,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

asthma; basogranulin; granulocytes; IL 35; NOD2; periostin

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CHEMOKINE RECEPTOR CCR3; HERPESVIRUS ENTRY MEDIATOR; INTERLEUKIN 17; INTERLEUKIN 35; TRANSCRIPTION FACTOR RUNX2; CYTOKINE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN; NOD2 PROTEIN, HUMAN;

ALLERGENICITY; ALLERGIC ASTHMA; ARTICLE; BASOPHIL; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MALE; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); PATIENT MONITORING; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; ADOLESCENT; ADULT; ASTHMA; BIOSYNTHESIS; GENE EXPRESSION REGULATION; HYPERSENSITIVITY; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ASTHMA; BIOMARKERS; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GRANULOCYTES; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; INTERLEUKINS; MALE; NOD2 SIGNALING ADAPTOR PROTEIN; YOUNG ADULT;

EID: 84925488303     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-0038-4     Document Type: Article

References (54)

1. Romagnani, S. 2004. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 112: 352–363.
2. Endo, Y., K. Hirahara, R. Yagi, D.J. Tumes, and T. Nakayama. 2014. Pathogenic memory type Th2 cells in allergic inflammation. Trends in Immunology 35: 69–78.
3. Rosenberg, H.F., K.D. Dyer, and P.S. Foster. 2013. Eosinophils: changing perspectives in health and disease. Nature Reviews Immunology 13: 9–22.
4. Geering, B., C. Stoeckle, S. Conus, and H.U. Simon. 2013. Living and dying for inflammation: neutrophils, eosinophils, basophils. Trends in Immunology 34: 398–409.
5. Hogan, S.P., H.F. Rosenberg, R. Moqbel, S. Phipps, P.S. Foster, P. Lacy, and A.B.. Kay. 2008. Eosinophils: biological properties and role in health and disease. Clinical and Experimental Allergy 38: 709–750.
6. Lemie’re, C., P. Ernst, R. Olivenstein, Y. Yamauchi, K. Govindaraju, M.S. Ludwig, J.G. Martin, and Q. Hamid. 2006. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. Journal of Allergy and Clinical Immunology 118: 1033–1039.
7. Wong, C.K., J. Cao, Y.B. Yin, and C.W. Lam. 2010. IL-17A activation on bronchial epithelial cells and basophils: a novel inflammatory mechanism. European Respiratory Journal 35: 883–893.
8. Wong, C.K., C.Y. Ho, F.W. Ko, C.H. Chan, A.S. Ho, D.S. Hui, and C.W. Lam. 2001. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clinical and Experimental Immunology 125: 177–183.
9. Leung, T.F., C.K. Wong, I.H. Chan, W.K. Ip, C.W. Lam, and G.W. Wong. 2002. Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthma. Journal of Allergy and Clinical Immunology 110: 404–409.
10. Lun, S.W., C.K. Wong, F.W. Ko, W.K. Ip, D.S. Hui, and C.W. Lam. 2006. Aberrant expression of CC and CXC chemokines and their receptors in patients with asthma. Journal of Clinical Immunology 26: 145–152.
11. Collison, L.W., and D.A. Vignali. 2008. Interleukin-35: odd one out or part of the family? Immunological Reviews 226: 248–262.
12. Collison, L.W., C.J. Workman, T.T. Kuo, K. Boyd, Y. Wang, K.M. Vignali, R. Cross, D. Sehy, R.S. Blumberg, and D.A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566–569.
13. Collison, L.W., V. Chaturvedi, A.L. Henderson, P.R. Giacomin, C. Guy, J. Bankoti, D. Finkelstein, K. Forbes, C.J. Workman, S.A. Brown, J.E. Rehg, M.L. Jones, H.T. Ni, D. Artis, M.J. Turk, and D.A. Vignali. 2010. IL-35-mediated induction of a potent regulatory T cell population. Nature Immunology 11: 1093–1101.
14. Chaturvedi, V., L.W. Collison, C.S. Guy, C.J. Workman, and D.A. Vignali. 2011. Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. Journal of Immunology 186: 6661–6666.
15. Collison, L.W., G.M. Delgoffe, C.S. Guy, K.M. Vignali, V. Chaturvedi, D. Fairweather, A.R. Satoskar, K.C. Garcia, C.A. Hunter, C.G. Drake, P.J. Murray, and D.A. Vignali. 2012. The composition and signaling of the IL-35 receptor are unconventional. Nature Immunology 13: 290–299.
16. Whitehead, G.S., R.H. Wilson, K. Nakano, L.H. Burch, H. Nakano, and D.N. Cook. 2012. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. Journal of Allergy and Clinical Immunology 129: 207–215.
17. Jia, G., R.W. Erickson, D.F. Choy, S. Mosesova, L.C. Wu, O.D. Solberg, A. Shikotra, R. Carter, S. Audusseau, Q. Hamid, P. Bradding, J.V. Fahy, P.G. Woodruff, J.M. Harris, and J.R. Arron. 2012. Bronchoscopic exploratory research study of biomarkers in corticosteroid-refractory asthma (BOBCAT) study group. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. Journal of Allergy and Clinical Immunology 130: 647–654.
18. Woodruff, P.G., H.A. Boushey, G.M. Dolganov, C.S. Barker, Y.H. Yang, S. Donnelly, A. Ellwanger, S.S. Sidhu, T.P. Dao-Pick, C. Pantoja, D.J. Erle, K.R. Yamamoto, and J.V. Fahy. 2007. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proceedings of the National Academy of Sciences of the United States of America 104: 15858–15863.
19. Yuyama, N., D.E. Davies, M. Akaiwa, K. Matsui, Y. Hamasaki, Y. Suminami, N.L. Yoshida, M. Maeda, A. Pandit, J.L. Lordan, Y. Kamogawa, K. Arima, F. Nagumo, M. Sugimachi, A. Berger, I. Richards, S.L. Roberds, T. Yamashita, F. Kishi, H. Kato, K. Arai, K. Ohshima, J. Tadano, N. Hamasaki, S. Miyatake, Y. Sugita, S.T. Holgate, and K. Izuhara. 2002. Analysis of novel disease-related genes in bronchial asthma. Cytokine 19: 287–296.
20. Takayama, G., K. Arima, T. Kanaji, S. Toda, H. Tanaka, S. Shoji, A.N. McKenzie, H. Nagai, T. Hotokebuchi, and K. Izuhara. 2006. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. Journal of Allergy and Clinical Immunology 118: 98–104.
21. Hayashi, N., T. Yoshimoto, K. Izuhara, K. Matsui, T. Tanaka, and K. Nakanishi. 2007. T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production. Proceedings of the National Academy of Sciences of the United States of America 104: 14765–14770.
22. Sidhu, S.S., S. Yuan, A.L. Innes, S. Kerr, P.G. Woodruff, L. Hou, S.J. Muller, and J.V. Fahy. 2010. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proceedings of the National Academy of Sciences of the United States of America 107: 14170–14175.
23. Schröder, N.W., T.R. Crother, Y. Naiki, S. Chen, M.H. Wong, A. Yilmaz, A. Slepenkin, D. Schulte, R. Alsabeh, T.M. Doherty, E. Peterson, A.E. Nel, and M. Arditi. 2008. Innate immune responses during respiratory tract infection with a bacterial pathogen induce allergic airway sensitization. Journal of Allergy and Clinical Immunology 122: 595–602.
24. Crother, T.R., N.W. Schröder, J. Karlin, S. Chen, K. Shimada, A. Slepenkin, R. Alsabeh, E. Peterson, and M. Arditi. 2011. Chlamydia pneumoniae infection induced allergic airway sensitization is controlled by regulatory T-cells and plasmacytoid dendritic cells. PLoS One 6: e20784.
25. Papadopoulos, N.G., I. Christodoulou, G. Rohde, I. Agache, C. Almqvist, A. Bruno, S. Bonini, L. Bont, A. Bossios, J. Bousquet, F. Braido, G. Brusselle, G.W. Canonica, K.H. Carlsen, P. Chanez, W.J. Fokkens, M. Garcia-Garcia, M. Gjomarkaj, T. Haahtela, S.T. Holgate, S.L. Johnston, G. Konstantinou, M. Kowalski, A. Lewandowska-Polak, K. Lødrup-Carlsen, M. Mäkelä, I. Malkusova, J. Mullol, A. Nieto, E. Eller, C. Ozdemir, P. Panzner, T. Popov, S. Psarras, E. Roumpedaki, M. Rukhadze, A. Stipic-Markovic, A. Todo Bom, E. Toskala, P. van Cauwenberge, C. van Drunen, J.B. Watelet, M. Xatzipsalti, P. Xepapadaki, and T. Zuberbier. 2011. Viruses and bacteria in acute asthma exacerbations—a GA2 LEN-DARE systematic review. Allergy 66: 458–68.
26. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805–820.
27. Carneiro, L.A., J.G. Magalhaes, I. Tattoli, D.J. Philpott, and L.H. Travassos. 2008. NOD-like proteins in inflammation and disease. Journal of Pathology 214: 136–148.
28. Schroder, K., and J. Tschopp. 2010. The inflammasomes. Cell 140: 821–832.
29. Tsuji, Y., T. Watanabe, M. Kudo, H. Arai, W. Strober, and T. Chiba. 2012. Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis. Immunity 37: 326–338.
30. Sabbah, A., T.H. Chang, R. Harnack, V. Frohlich, K. Tominaga, P.H. Dube, Y. Xiang, and S. Bose. 2009. Activation of innate immune antiviral responses by Nod2. Nature Immunology 10: 1073–1080.
31. Pedra, J.H., S.L. Cassel, and F.S. Sutterwala. 2009. Sensing pathogens and danger signals by the inflammasome. Current Opinion in Immunology 21: 10–16.
32. Magalhaes, J.G., J.H. Fritz, L. le Bourhis, G. Sellge, L.H. Travassos, T. Selvanantham, S.E. Girardin, J.L. Gommerman, and D.J. Philpott. 2008. Nod2-dependent Th2 polarization of antigen-specific immunity. Journal of Immunology 181: 7925–7935.
33. Ogura, Y., D.K. Bonen, N. Inohara, D.L. Nicolae, F.F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R.H. Duerr, J.P. Achkar, S.R. Brant, T.M. Bayless, B.S. Kirschner, S.B. Hanauer, G. Nuñez, and J.H. Cho. 2001. A frame shift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411: 603–606.
34. H2-driven allergic inflammation. Journal of Allergy and Clinical Immunology 126: 1284–1293.
35. Reijmerink, N.E1., R.W. Bottema, M. Kerkhof, J. Gerritsen, F.F. Stelma, C. Thijs, C.P. van Schayck, H.A. Smit, B. Brunekreef, G.H. Koppelman, and D.S. Postma. 2010. TLR-related pathway analysis: novel gene-gene interactions in the development of asthma and atopy. Allergy 65: 199–207.
36. Kvarnhammar, A.M., T. Petterson, and L.O. Cardell. 2011. NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists. Immunology 134: 314–325.
37. Qiu, H.N., C.K. Wong, I.M. Chu, S. Hu, and C.W. Lam. 2013. Muramyl dipeptide mediated activation of human bronchial epithelial cells interacting with basophils: a novel mechanism of airway inflammation. Clinical and Experimental Immunology 172: 81–94.
38. Wong, C.K., S. Hu, K.M. Leung, J. Dong, L. He, Y.J. Chu, I.M. Chu, H.N. Qiu, K.Y. Liu, and C.W. Lam. 2013. NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma. Cellular & Molecular Immunology 10: 317–329.
39. American Thoracic Society: Medical section of the American Lung Association. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. American Review of Respiratory Disease 136: 225–244.
40. American Thoracic Society. 1995. Standardization of spirometry, 1994 update. American Journal of Respiratory and Critical Care Medicine 152: 1107–1136.
41. Lam, K.K., S.C. Pang, W.G. Allan, L.E. Hill, N.J. Snell, P.M. Fayers, A.J. Nunn, and F.J. Prime. 1983. Predictive nomograms for forced expiratory volume, forced vital capacity, and peak expiratory flow rate, in Chinese adults and children. British Journal of Diseases of the Chest 77: 390–396.
42. Brooks, S.M., L. Bernstein, P.K. Raghuprasad, C.A. Maccia, and L. Mieczkowski. 1990. Assessment of airway hyperresponsiveness in chronic stable asthma. Journal of Allergy and Clinical Immunology 85: 17–26.
43. Lam, C.W., H.K. Fung, L.P. Vrijmoed, L.C. Lit, M.C. Wong, J.K. Woo, and N.M. Hjelm. 1998. Aetiology of allergic rhinitis in Hong Kong. Allergology International 47: 23–28.
44. Leung, T.F., H.Y. Sy, G.W. Wong, M.C. Ng, I.H. Chan, C.Y. Li, N.L. Tang, M.W. Waye, and C.W. Lam. 2009. Asthma and atopy are associated with chromosome 17q21 markers in Chinese children. Allergy 64: 621–628.
45. Chirumbolo, S. 2012. Basophil activation test in allergy: time for an update? International Archives of Allergy and Immunology 158: 99–114.
46. Wong, C.K., S.W. Lun, F.W. Ko, P.T. Wong, S.Q. Hu, I.H. Chan, D.S. Hui, and C.W. Lam. 2009. Activation of peripheral Th17 lymphocytes in patients with asthma. Immunological Investigations 38: 652–664.
47. Kinoshita, T., A. Baatjes, S.G. Smith, B. Dua, R. Watson, T. Kawayama, M. Larche, G.M. Gauvreau, and P.M. O’Byrne. 2014. Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma. Journal of Allergy and Clinical Immunology 133: 696–703.
48. Mäkelä, M.J., A. Kanehiro, L. Borish, A. Dakhama, J. Loader, A. Joetham, Z. Xing, M. Jordana, G.L. Larsen, and E.W. Gelfand. 2000. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proceedings of the National Academy of Sciences of the United States of America 97: 6007–6012.
49. Halwani, R., S. Al-Muhsen, H. Al-Jahdali, and Q. Hamid. 2011. Role of transforming growth factor-β in airway remodeling in asthma. American Journal of Respiratory Cell and Molecular Biology 44: 127–133.
50. Huang, C.H., E.X. Loo, I.C. Kuo, G.H. Soh, D.L. Goh, B.W. Lee, and K.Y. Chua. 2011. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. Journal of Immunology 187: 462–471.
51. Mochizuki, A., A.R. McEuen, M.G. Buckley, and A.F. Walls. 2003. The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: validity of basogranulin measurement as an indicator of basophil activation. Journal of Allergy and Clinical Immunology 112: 102–208.
52. Lun, S.W., C.K. Wong, F.W. Ko, D.S. Hui, and C.W. Lam. 2009. Expression and functional analysis of toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma. Journal of Clinical Immunology 29: 330–342.
53. Doherty, T.A., P. Soroosh, N. Khorram, S. Fukuyama, P. Rosenthal, J.Y. Cho, P.S. Norris, H. Choi, S. Scheu, K. Pfeffer, B.L. Zuraw, C.F. Ware, D.H. Broide, and M. Croft. 2011. The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling. Nature Medicine 17: 596–603.
54. Hastie, A.T., W.C. Moore, D.A. Meyers, P.L. Vestal, H. Li, S.P. Peters, E.R. Bleecker, and National Heart, Lung, and Blood Institute Severe Asthma Research Program. 2010. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. Journal of Allergy and Clinical Immunology 125: 1028–1036.